Advances in Clinical Study of Curcumin

Author(s): Chunfen Yang, Xun Su, Anchang Liu, Lin Zhang, Aihua Yu, Yanwei Xi, Guangxi Zhai

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 11 , 2013

Become EABM
Become Reviewer


Curcumin has been estimated as a potential agent for many diseases and attracted great attention owing to its various pharmacological activities, including anti-cancer, and anti-inflammatory. Now curcumin is being applied to a number of patients with breast cancer, rheumatoid arthritis, Alzheimer's disease, colorectal cancer, psoriatic, etc. Several clinical trials have stated that curcumin is safe enough and effective. The objective of this article was to summarize the clinical studies of curcumin, and give a reference for future studies.

Keywords: Curcumin, Alzheimer's disease, colorectal cancer, pancreatic cancer, breast cancer, familial adenomatous polyposis, gall-bladder contraction, tropical pancreatitis, anti-cancer, anti-inflammatory

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 13 February, 2013
Page: [1966 - 1973]
Pages: 8
DOI: 10.2174/1381612811319110002
Price: $65

Article Metrics

PDF: 45